Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2000
05/17/2000CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
05/17/2000CN1253560A Sulfonamides for treatment of endothelin-mediated disorders
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253558A Substituted imidazoles useful in treatment of inflammatory diseases
05/17/2000CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/17/2000CN1253504A Cytokine related treatments of disease
05/17/2000CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders
05/17/2000CN1253501A IL-8 receptor antagonists
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1052404C Snakehead oral liquid
05/16/2000US6063934 Neuropeptide y antagonists
05/16/2000US6063927 Paroxetine derivatives
05/16/2000US6063911 Methods and compositions for treatment of cell proliferative disorders
05/16/2000US6063903 Ligands for EPH-like receptors
05/16/2000US6063817 Antiischemic agents
05/16/2000US6063816 Hydroxamic acid compounds
05/16/2000US6063812 Angiogenesis inhibitors, antiarthritic agents and anticarcinogenic agents plus synthesis
05/16/2000US6063807 Cyclo-oxygenase inhibitor and amidine derivatives salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts
05/16/2000US6063804 Pyrrole compounds
05/16/2000US6063802 Ondansetron freeze-dried dosage form compositions for oral administration
05/16/2000US6063801 Heterocyclic topoisomerase poisons
05/16/2000US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor
05/16/2000US6063796 Heterocyclic compounds of piperidine
05/16/2000US6063791 N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use
05/16/2000US6063769 1-thiogalactose derivatives
05/16/2000US6063766 Drugs and proteins from blood with amino acid sequences
05/16/2000US6063760 Proteins with amino acid sequences
05/16/2000US6063623 Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, DNA sequences encoding it and their use
05/16/2000US6063361 Administering to a patient at least one cascade polymer complex and subjecting the patient to a radiology diagnosis
05/16/2000US6063116 Modulation of cell proliferation and wound healing
05/16/2000CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists
05/16/2000CA2170255C Pharmaceutical composition for immunoenhancement therapy
05/16/2000CA2126752C Benzopyran and related ltb4 antagonists
05/16/2000CA2098893C Antioxidant composition of natural products and method of production thereof
05/16/2000CA2081637C Rhenium and technetium complexes containing a hypoxia-localizing moiety
05/13/2000CA2289329A1 A suppressive agent against expression of cell adhesion molecules
05/12/2000CA2288680A1 Modulation of cell proliferative disorders by cyclic rgd
05/11/2000WO2000026399A2 Method for the production of quercetin and isoquercetin derivatives
05/11/2000WO2000026397A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS)
05/11/2000WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
05/11/2000WO2000026360A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/11/2000WO2000026347A1 Methods for the production of tcr gamma delta t cells
05/11/2000WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME
05/11/2000WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
05/11/2000WO2000026218A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/11/2000WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors
05/11/2000WO2000026211A1 Thrombin inhibitors
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026206A1 Method for producing luteolin and luteolin derivatives
05/11/2000WO2000026204A1 Novel optically active aminopentane derivative
05/11/2000WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000026199A2 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
05/11/2000WO2000026197A1 Novel inhibitors of impdh enzyme
05/11/2000WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
05/11/2000WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody
05/11/2000WO2000025795A1 Compositions comprising a mixture of bioflavonols
05/11/2000WO2000025794A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
05/11/2000WO2000025788A1 Inhibitors of prenyl-protein transferase
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025783A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder
05/11/2000WO2000025781A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
05/11/2000WO2000025780A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
05/11/2000WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025771A1 Method for preventing increased iridial pigmentation during prostaglandin treatment
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases
05/11/2000WO2000025752A1 Multiparticulate modified release composition
05/11/2000WO2000025725A2 Functional antagonists of hedgehog activity
05/11/2000WO2000025723A2 Methods and compositions for the prevention of tolerance to medications
05/11/2000WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
05/11/2000WO2000018381A8 Use of epinastine as antitussivum
05/11/2000WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
05/11/2000WO2000008130A3 Method for preparing a cartilage cell suspension
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof
05/11/2000WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/11/2000WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000DE19847364C1 Tumor-Protein Tumor protein
05/11/2000CA2653839A1 Multiparticulate modified release composition
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349482A1 Pharmaceutical compounds
05/11/2000CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
05/11/2000CA2349427A1 Method for preventing increased iridial pigmentation during prostaglandin treatment
05/11/2000CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2349158A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000CA2348910A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
05/11/2000CA2348756A1 Enhanced vaccines
05/11/2000CA2348734A1 Thrombin inhibitors
05/11/2000CA2348728A1 Method for the production of quercetin and isoquercetin derivatives
05/11/2000CA2348703A1 Inhibitors of prenyl-protein transferase
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
1 ... 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 ... 1564